Rare germline TP53 variants in lung adenocarcinoma.

Authors

null

Erin Michelle Parry

Osler Medical Housestaff Training Program, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD

Erin Michelle Parry , Dustin L Gable , Susan E Stanley , Mary Y. Armanios

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2015 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Cancer Prevention, Genetics, and Epidemiology

Track

Prevention, Risk Reduction, and Genetics

Sub Track

Cancer Genetics

Citation

J Clin Oncol 33, 2015 (suppl; abstr 1548)

DOI

10.1200/jco.2015.33.15_suppl.1548

Abstract #

1548

Poster Bd #

372

Abstract Disclosures

Similar Posters

Poster

2021 ASCO Annual Meeting

<em><i>TP53</i></em> and <em><i>CHEK2</i></em> germline mutations in malignant solid tumors.

TP53 and CHEK2 germline mutations in malignant solid tumors.

First Author: Zhiye Zhang

Poster

2021 ASCO Annual Meeting

Racial disparities in lung adenocarcinoma: The contribution of African ancestry.

Racial disparities in lung adenocarcinoma: The contribution of African ancestry.

First Author: Michelle Jeung-Eun Lee

Poster

2019 ASCO Annual Meeting

Germline mutations and onset of lung adenocarcinoma in smokers and nonsmokers.

Germline mutations and onset of lung adenocarcinoma in smokers and nonsmokers.

First Author: Karen L. Reckamp

First Author: Daniele Paixao